Advertisement

FDA Recalls Another Batch of Generic Metoprolol — Physician’s First Watch

Medical News |
June 25, 2014

FDA Recalls Another Batch of Generic Metoprolol

By Larry Husten

Edited by David G. Fairchild, MD, MPH, and Richard Saitz, MD, MPH, FACP, FASAM

The FDA has recalled more than 13,000 bottles of metoprolol succinate extended-release tablets manufactured by Dr. Reddy's Laboratories, Reuters reported late last week. In addition, the agency recently recalled another lot of generic metoprolol from a different company, Wockhardt. Both recalls were for medicines manufactured at facilities in India.

The recalls were categorized as Class II, which the FDA says "may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."

A New York Times story details the long-simmering and growing concerns of Cleveland Clinic cardiologist Harry Lever over generic metoprolol. Lever reported his concerns to the FDA and attempted to get Congress involved, but he could not prove the generics were at fault. "You see enough people and you get a feel, but it's anecdotes. It's not science," Lever told the Times. Now, he "is feeling a sort of sad vindication," the Times reports.

Adapted from CardioExchange

Reader Comments (1)

David Foster, MD Physician, Family Medicine/General Practice, Oregon

Insurers & Government: "We don't want it GOOD, we want it CHEAP!"

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement